1
|
Abdullah H, Gao H, Tatomir A, Sauter M. A steady-state kinetic interface-sensitive tracer (KIS-SST) method to measure capillary associated interfacial area in a simultaneous co-flow condition. J Contam Hydrol 2023; 257:104217. [PMID: 37379622 DOI: 10.1016/j.jconhyd.2023.104217] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/03/2023] [Revised: 05/26/2023] [Accepted: 06/11/2023] [Indexed: 06/30/2023]
Abstract
We propose a novel method to measure the specific capillary-associated interfacial area (awn) between non-wetting and wetting fluids by applying kinetic interface-sensitive (KIS) tracers under steady-state two-phase co-flow conditions. Seven column experiments were conducted with a column filled with glass beads (diameter d50 = 170 μm), serving as the solid grain network of a porous granular material. The experiments were performed for two flow scenarios, i.e., five experiments were performed for drainage conditions (increasing non-wetting saturation) and two experiments for imbibition conditions (increasing wetting saturation). To obtain different saturation levels in the column and, consequently, different capillarity-induced interfacial areas between the fluids, the experiments were performed for different fractional flow ratios (i.e., the ratio between injection rate of the wetting phase and total injection rate). The concentrations of the KIS tracer reaction by-product were recorded at each saturation level and the corresponding interfacial area was calculated. As a result of the fractional flow condition a wide range of wetting phase saturation is created (0.3 < Sw < 0.8). The measured awn increases with decreasing wetting phase saturation for the range 0.55 < Sw < 0.8, and then is followed by a drop in wetting phase saturation of 0.3 < Sw < 0.55. A good fit for our calculated awn is obtained (RMSE <0.16) using a polynomial model. Additionally, the results of the proposed method are compared to published experimental data and the method's main advantages and limitations are discussed.
Collapse
Affiliation(s)
- H Abdullah
- Department of Applied Geology, Geoscience Centre of the University of Göttingen, Goldschmidtstr. 3, 37077 Göttingen, Germany.
| | - H Gao
- Department of Applied Geology, Geoscience Centre of the University of Göttingen, Goldschmidtstr. 3, 37077 Göttingen, Germany
| | - A Tatomir
- Department of Applied Geology, Geoscience Centre of the University of Göttingen, Goldschmidtstr. 3, 37077 Göttingen, Germany
| | - M Sauter
- Department of Applied Geology, Geoscience Centre of the University of Göttingen, Goldschmidtstr. 3, 37077 Göttingen, Germany
| |
Collapse
|
2
|
Kraft M, Wiedmann F, Foerster KI, Sauter M, Paasche A, Blochberger PL, Yesilgoez B, L'hoste Y, Arif R, Warnecke G, Karck M, Frey N, Burhenne J, Haefeli WE, Schmidt C. Comparison of the antiarrhythmic potential of doxapram and its metabolite ketodoxaparam. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.2693] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
A few years ago, the TASK-1 channel has been established as a potential new target for the therapy of atrial fibrillation (AF). In the heart, TASK-1 is almost exclusively expressed in the atria and is significantly upregulated in AF patients. Therefore, it plays an important role in the shortening of the atrial action potential observed during AF, making TASK-1 a promising target for AF therapy. This could be proven in a porcine model of persistent AF in which an intravenous application of the TASK-1 inhibitor doxapram led to a termination of AF and the restoration of sinus rhythm (SR). Doxapram's metabolite ketodoxapam is described in the literature as being active with limited data available on its usage. Therefore, the effect of ketodoxapram on TASK-1 and its possible use in AF therapy still needs to be investigated.
Purpose
The purpose of the present study was to assess the potential of ketodoxapram in the termination of AF. Furthermore, a comparison between doxapram and ketodoxapram was performed based on electrophysiological and pharmacological data.
Methods
UPLC-MS/MS assays were developed and validated for the measurement of doxapram and ketodoxapram in porcine plasma and brain tissue. Using these assays, the pharmacokinetics of both substances, after intravenous injections of 1 mg/kg, were determined in pigs. Furthermore, brain and plasma concentrations were measured to assess brain-to-plasma ratios. A porcine AF model was used to estimate the antiarrhythmic potential. Electrophysiological properties were evaluated, using two-electrode voltage clamp experiment on Xenopus laevis oocytes which heterologously expressed atrial potassium channels, to calculate the effect of doxapram and ketodoxapram on channel function. Furthermore, whole-cell patch clamp measurements were performed on isolated human cardiomyocytes.
Results
Doxapram and ketodoxapram showed strong inhibitory effects on TASK-1 (IC50 1.0 μM and 0.8 μM) and TASK-3 (5.9 μM and 1.5 μM), but no significant effect on the other measured ion channels. The maximal inhibition on TASK-1 was 96%. The brain-to-plasma ratio for doxapram (0.58) was almost ten-fold higher than for ketodoxapram (0.065), hinting at a reduced crossing of the blood-brain barrier (BBB) for ketodoxapram. The terminal half-life (t1/2) of ketodoxapram (1.71 h) was longer and the maximal concentration (Cmax; 4,604 ng/ml) was higher than for doxapram (1.38 h; 1,780 ng/ml). In a porcine model of AF, ketodoxapram led to a significantly reduced AF burdens comparable to doxapram.
Conclusions
Doxapram and ketodoxapram both show strong inhibitory effects on TASK-1, making them good candidates for a TASK-1 based AF therapy. Ketodoxapram with its longer t1/2, reduced crossing of the BBB and higher Cmax points towards a possible superiority in the treatment of AF compared to doxapram. Studies in a porcine AF model showed promising results for the use of doxapram and ketodoxapram in AF therapy.
Funding Acknowledgement
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): German Research Foundation
Collapse
Affiliation(s)
- M Kraft
- University Hospital of Heidelberg , Heidelberg , Germany
| | - F Wiedmann
- University Hospital of Heidelberg , Heidelberg , Germany
| | - K I Foerster
- University Hospital of Heidelberg , Heidelberg , Germany
| | - M Sauter
- University Hospital of Heidelberg , Heidelberg , Germany
| | - A Paasche
- University Hospital of Heidelberg , Heidelberg , Germany
| | | | - B Yesilgoez
- University Hospital of Heidelberg , Heidelberg , Germany
| | - Y L'hoste
- University Hospital of Heidelberg , Heidelberg , Germany
| | - R Arif
- University Hospital of Heidelberg , Heidelberg , Germany
| | - G Warnecke
- University Hospital of Heidelberg , Heidelberg , Germany
| | - M Karck
- University Hospital of Heidelberg , Heidelberg , Germany
| | - N Frey
- University Hospital of Heidelberg , Heidelberg , Germany
| | - J Burhenne
- University Hospital of Heidelberg , Heidelberg , Germany
| | - W E Haefeli
- University Hospital of Heidelberg , Heidelberg , Germany
| | - C Schmidt
- University Hospital of Heidelberg , Heidelberg , Germany
| |
Collapse
|
3
|
Andreev V, Arratia M, Baghdasaryan A, Baty A, Begzsuren K, Belousov A, Bolz A, Boudry V, Brandt G, Britzger D, Buniatyan A, Bystritskaya L, Campbell AJ, Cantun Avila KB, Cerny K, Chekelian V, Chen Z, Contreras JG, Cunqueiro Mendez L, Cvach J, Dainton JB, Daum K, Deshpande A, Diaconu C, Eckerlin G, Egli S, Elsen E, Favart L, Fedotov A, Feltesse J, Fleischer M, Fomenko A, Gal C, Gayler J, Goerlich L, Gogitidze N, Gouzevitch M, Grab C, Greenshaw T, Grindhammer G, Haidt D, Henderson RCW, Hessler J, Hladký J, Hoffmann D, Horisberger R, Hreus T, Huber F, Jacobs PM, Jacquet M, Janssen T, Jung AW, Jung H, Kapichine M, Katzy J, Kiesling C, Klein M, Kleinwort C, Klest HT, Kogler R, Kostka P, Kretzschmar J, Krücker D, Krüger K, Landon MPJ, Lange W, Laycock P, Lee SH, Levonian S, Li W, Lin J, Lipka K, List B, List J, Lobodzinski B, Malinovski E, Martyn HU, Maxfield SJ, Mehta A, Meyer AB, Meyer J, Mikocki S, Mondal MM, Morozov A, Müller K, Nachman B, Naumann T, Newman PR, Niebuhr C, Nowak G, Olsson JE, Ozerov D, Park S, Pascaud C, Patel GD, Perez E, Petrukhin A, Picuric I, Pitzl D, Polifka R, Preins S, Radescu V, Raicevic N, Ravdandorj T, Reimer P, Rizvi E, Robmann P, Roosen R, Rostovtsev A, Rotaru M, Sankey DPC, Sauter M, Sauvan E, Schmitt S, Schmookler BA, Schoeffel L, Schöning A, Sefkow F, Shushkevich S, Soloviev Y, Sopicki P, South D, Spaskov V, Specka A, Steder M, Stella B, Straumann U, Sun C, Sykora T, Thompson PD, Traynor D, Tseepeldorj B, Tu Z, Valkárová A, Vallée C, Van Mechelen P, Wegener D, Wünsch E, Žáček J, Zhang J, Zhang Z, Žlebčík R, Zohrabyan H, Zomer F. Measurement of Lepton-Jet Correlation in Deep-Inelastic Scattering with the H1 Detector Using Machine Learning for Unfolding. Phys Rev Lett 2022; 128:132002. [PMID: 35426724 DOI: 10.1103/physrevlett.128.132002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/30/2021] [Revised: 12/20/2021] [Accepted: 02/25/2022] [Indexed: 06/14/2023]
Abstract
The first measurement of lepton-jet momentum imbalance and azimuthal correlation in lepton-proton scattering at high momentum transfer is presented. These data, taken with the H1 detector at HERA, are corrected for detector effects using an unbinned machine learning algorithm (multifold), which considers eight observables simultaneously in this first application. The unfolded cross sections are compared with calculations performed within the context of collinear or transverse-momentum-dependent factorization in quantum chromodynamics as well as Monte Carlo event generators.
Collapse
Affiliation(s)
- V Andreev
- Lebedev Physical Institute, Moscow, Russia
| | - M Arratia
- University of California, Riverside, California 92521, USA
| | | | - A Baty
- Rice University, Houston, Texas 77005-1827, USA
| | - K Begzsuren
- Institute of Physics and Technology of the Mongolian Academy of Sciences, Ulaanbaatar, Mongolia
| | - A Belousov
- Lebedev Physical Institute, Moscow, Russia
| | - A Bolz
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - V Boudry
- LLR, Ecole Polytechnique, CNRS/IN2P3, Palaiseau, France
| | - G Brandt
- II. Physikalisches Institut, Universität Göttingen, Göttingen, Germany
| | - D Britzger
- Max-Planck-Institut für Physik, München, Germany
| | - A Buniatyan
- School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
| | - L Bystritskaya
- Institute for Theoretical and Experimental Physics, Moscow, Russia
| | - A J Campbell
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - K B Cantun Avila
- Departamento de Fisica Aplicada, CINVESTAV, Mérida, Yucatán, México
| | - K Cerny
- Joint Laboratory of Optics, Palacký University, Olomouc, Czech Republic
| | - V Chekelian
- Max-Planck-Institut für Physik, München, Germany
| | - Z Chen
- Shandong University, Shandong, People's Republic of China
| | - J G Contreras
- Departamento de Fisica Aplicada, CINVESTAV, Mérida, Yucatán, México
| | | | - J Cvach
- Institute of Physics, Academy of Sciences of the Czech Republic, Praha, Czech Republic
| | - J B Dainton
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - K Daum
- Fachbereich C, Universität Wuppertal, Wuppertal, Germany
| | - A Deshpande
- Stony Brook University, Stony Brook, New York 11794, USA
| | - C Diaconu
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
| | - G Eckerlin
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - S Egli
- Paul Scherrer Institut, Villigen, Switzerland
| | - E Elsen
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - L Favart
- Inter-University Institute for High Energies ULB-VUB, Brussels and Universiteit Antwerpen, Antwerp, Belgium
| | - A Fedotov
- Institute for Theoretical and Experimental Physics, Moscow, Russia
| | - J Feltesse
- Irfu/SPP, CE Saclay, Gif-sur-Yvette, France
| | - M Fleischer
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - A Fomenko
- Lebedev Physical Institute, Moscow, Russia
| | - C Gal
- Stony Brook University, Stony Brook, New York 11794, USA
| | - J Gayler
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - L Goerlich
- Institute of Nuclear Physics Polish Academy of Sciences, Krakow, Poland
| | | | - M Gouzevitch
- Université Claude Bernard Lyon 1, CNRS/IN2P3, Villeurbanne, France
| | - C Grab
- Institut für Teilchenphysik, ETH, Zürich, Switzerland
| | - T Greenshaw
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | | | - D Haidt
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - R C W Henderson
- Department of Physics, University of Lancaster, Lancaster, United Kingdom
| | - J Hessler
- Max-Planck-Institut für Physik, München, Germany
| | - J Hladký
- Institute of Physics, Academy of Sciences of the Czech Republic, Praha, Czech Republic
| | - D Hoffmann
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
| | | | - T Hreus
- Physik-Institut der Universität Zürich, Zürich, Switzerland
| | - F Huber
- Physikalisches Institut, Universität Heidelberg, Heidelberg, Germany
| | - P M Jacobs
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - M Jacquet
- IJCLab, Université Paris-Saclay, CNRS/IN2P3, Orsay, France
| | - T Janssen
- Inter-University Institute for High Energies ULB-VUB, Brussels and Universiteit Antwerpen, Antwerp, Belgium
| | - A W Jung
- Department of Physics and Astronomy, Purdue University, West Lafayette, Indiana 47907, USA
| | - H Jung
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - M Kapichine
- Joint Institute for Nuclear Research, Dubna, Russia
| | - J Katzy
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - C Kiesling
- Max-Planck-Institut für Physik, München, Germany
| | - M Klein
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - C Kleinwort
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - H T Klest
- Stony Brook University, Stony Brook, New York 11794, USA
| | - R Kogler
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - P Kostka
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - J Kretzschmar
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - D Krücker
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - K Krüger
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - M P J Landon
- School of Physics and Astronomy, Queen Mary, University of London, London, United Kingdom
| | - W Lange
- Deutsches Elektronen-Synchrotron DESY, Zeuthen, Germany
| | - P Laycock
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - S H Lee
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - S Levonian
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - W Li
- Rice University, Houston, Texas 77005-1827, USA
| | - J Lin
- Rice University, Houston, Texas 77005-1827, USA
| | - K Lipka
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - B List
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - J List
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | | | | | - H-U Martyn
- I. Physikalisches Institut der RWTH, Aachen, Germany
| | - S J Maxfield
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - A Mehta
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - A B Meyer
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - J Meyer
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - S Mikocki
- Institute of Nuclear Physics Polish Academy of Sciences, Krakow, Poland
| | - M M Mondal
- Stony Brook University, Stony Brook, New York 11794, USA
| | - A Morozov
- Joint Institute for Nuclear Research, Dubna, Russia
| | - K Müller
- Physik-Institut der Universität Zürich, Zürich, Switzerland
| | - B Nachman
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - Th Naumann
- Deutsches Elektronen-Synchrotron DESY, Zeuthen, Germany
| | - P R Newman
- School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
| | - C Niebuhr
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - G Nowak
- Institute of Nuclear Physics Polish Academy of Sciences, Krakow, Poland
| | - J E Olsson
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - D Ozerov
- Paul Scherrer Institut, Villigen, Switzerland
| | - S Park
- Stony Brook University, Stony Brook, New York 11794, USA
| | - C Pascaud
- IJCLab, Université Paris-Saclay, CNRS/IN2P3, Orsay, France
| | - G D Patel
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | | | - A Petrukhin
- Université Claude Bernard Lyon 1, CNRS/IN2P3, Villeurbanne, France
| | - I Picuric
- Faculty of Science, University of Montenegro, Podgorica, Montenegro
| | - D Pitzl
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - R Polifka
- Faculty of Mathematics and Physics, Charles University, Praha, Czech Republic
| | - S Preins
- University of California, Riverside, California 92521, USA
| | - V Radescu
- Department of Physics, Oxford University, Oxford, United Kingdom
| | - N Raicevic
- Faculty of Science, University of Montenegro, Podgorica, Montenegro
| | - T Ravdandorj
- Institute of Physics and Technology of the Mongolian Academy of Sciences, Ulaanbaatar, Mongolia
| | - P Reimer
- Institute of Physics, Academy of Sciences of the Czech Republic, Praha, Czech Republic
| | - E Rizvi
- School of Physics and Astronomy, Queen Mary, University of London, London, United Kingdom
| | - P Robmann
- Physik-Institut der Universität Zürich, Zürich, Switzerland
| | - R Roosen
- Inter-University Institute for High Energies ULB-VUB, Brussels and Universiteit Antwerpen, Antwerp, Belgium
| | - A Rostovtsev
- Institute for Information Transmission Problems RAS, Moscow, Russia
| | - M Rotaru
- Horia Hulubei National Institute for R&D in Physics and Nuclear Engineering (IFIN-HH), Bucharest, Romania
| | - D P C Sankey
- STFC, Rutherford Appleton Laboratory, Didcot, Oxfordshire, United Kingdom
| | - M Sauter
- Physikalisches Institut, Universität Heidelberg, Heidelberg, Germany
| | - E Sauvan
- LAPP, Université de Savoie, CNRS/IN2P3, Annecy-le-Vieux, France
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
| | - S Schmitt
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - B A Schmookler
- Stony Brook University, Stony Brook, New York 11794, USA
| | | | - A Schöning
- Physikalisches Institut, Universität Heidelberg, Heidelberg, Germany
| | - F Sefkow
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - S Shushkevich
- Lomonosov Moscow State University, Skobeltsyn Institute of Nuclear Physics, Moscow, Russia
| | - Y Soloviev
- Lebedev Physical Institute, Moscow, Russia
| | - P Sopicki
- Institute of Nuclear Physics Polish Academy of Sciences, Krakow, Poland
| | - D South
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - V Spaskov
- Joint Institute for Nuclear Research, Dubna, Russia
| | - A Specka
- LLR, Ecole Polytechnique, CNRS/IN2P3, Palaiseau, France
| | - M Steder
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - B Stella
- Dipartimento di Fisica Università di Roma Tre and INFN Roma 3, Roma, Italy
| | - U Straumann
- Physik-Institut der Universität Zürich, Zürich, Switzerland
| | - C Sun
- Shandong University, Shandong, People's Republic of China
| | - T Sykora
- Faculty of Mathematics and Physics, Charles University, Praha, Czech Republic
| | - P D Thompson
- School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
| | - D Traynor
- School of Physics and Astronomy, Queen Mary, University of London, London, United Kingdom
| | - B Tseepeldorj
- Institute of Physics and Technology of the Mongolian Academy of Sciences, Ulaanbaatar, Mongolia
- Ulaanbaatar University, Ulaanbaatar, Mongolia
| | - Z Tu
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - A Valkárová
- Faculty of Mathematics and Physics, Charles University, Praha, Czech Republic
| | - C Vallée
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
| | - P Van Mechelen
- Inter-University Institute for High Energies ULB-VUB, Brussels and Universiteit Antwerpen, Antwerp, Belgium
| | - D Wegener
- Institut für Physik, TU Dortmund, Dortmund, Germany
| | - E Wünsch
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - J Žáček
- Faculty of Mathematics and Physics, Charles University, Praha, Czech Republic
| | - J Zhang
- Shandong University, Shandong, People's Republic of China
| | - Z Zhang
- IJCLab, Université Paris-Saclay, CNRS/IN2P3, Orsay, France
| | - R Žlebčík
- Faculty of Mathematics and Physics, Charles University, Praha, Czech Republic
| | | | - F Zomer
- IJCLab, Université Paris-Saclay, CNRS/IN2P3, Orsay, France
| |
Collapse
|
4
|
Sauter M, Langer HF. Targeting Cell-Specific Molecular Mechanisms of Innate Immunity in Atherosclerosis. Front Physiol 2022; 13:802990. [PMID: 35432000 PMCID: PMC9010538 DOI: 10.3389/fphys.2022.802990] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2021] [Accepted: 03/07/2022] [Indexed: 11/13/2022] Open
Abstract
Mechanisms of innate immunity contribute to inflammation, one of the major underlying causes of atherogenesis and progression of atherosclerotic vessel disease. How immune cells exactly contribute to atherosclerosis and interact with molecules of cholesterol homeostasis is still a matter of intense research. Recent evidence has proposed a potential role of previously underappreciated cell types in this chronic disease including platelets and dendritic cells (DCs). The pathophysiology of atherosclerosis is studied in models with dysfunctional lipid homeostasis and several druggable molecular targets are derived from these models. Specific therapeutic approaches focussing on these immune mechanisms, however, have not been successfully introduced into everyday clinical practice, yet. This review highlights molecular insights into immune processes related to atherosclerosis and potential future translational approaches targeting these molecular mechanisms.
Collapse
Affiliation(s)
- M. Sauter
- Cardioimmunology Group, Medical Clinic II, University Heart Center Lübeck, Lübeck, Germany
| | - H. F. Langer
- Cardioimmunology Group, Medical Clinic II, University Heart Center Lübeck, Lübeck, Germany
- Department of Cardiology, University Heart Center Luebeck, University Hospital, Luebeck, Germany
- DZHK (German Centre for Cardiovascular Research), Partner Site Hamburg/Lübeck/Kiel, Lübeck, Germany
- *Correspondence: H. F. Langer,
| |
Collapse
|
5
|
Sauter M, Müller C, Barthelme J, Brendler C, Liebers F. Heben und Tragen schwerer Lasten als berufliche Expositionen in verschiedenen Berufsgruppen und Rückenschmerzen – Ergebnisse der BIBB/BAuA Erwerbstätigenbefragung 2018. Das Gesundheitswesen 2021. [DOI: 10.1055/s-0041-1732187] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- M Sauter
- Bundesanstalt für Arbeitsschutz und Arbeitsmedizin
- Berlin School of Public Health
| | - C Müller
- Bundesanstalt für Arbeitsschutz und Arbeitsmedizin
- Berlin School of Public Health
| | - J Barthelme
- Bundesanstalt für Arbeitsschutz und Arbeitsmedizin
- Berlin School of Public Health
| | - C Brendler
- Bundesanstalt für Arbeitsschutz und Arbeitsmedizin
| | - F Liebers
- Bundesanstalt für Arbeitsschutz und Arbeitsmedizin
| |
Collapse
|
6
|
Barthelme J, Liebers F, Müller C, Sauter M, Brendler C. Körperzwangshaltungen (Arbeiten über Kopf) und deren Assoziation zu Schmerzen im Nacken-Schulter-Bereich – themenspezifische Auswertung einer Querschnittsbefragung deutscher Erwerbstätiger. Das Gesundheitswesen 2021. [DOI: 10.1055/s-0041-1732089] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- J Barthelme
- Bundesanstalt für Arbeitsschutz und Arbeitsmedizin
| | - F Liebers
- Bundesanstalt für Arbeitsschutz und Arbeitsmedizin
| | - C Müller
- Bundesanstalt für Arbeitsschutz und Arbeitsmedizin
| | - M Sauter
- Bundesanstalt für Arbeitsschutz und Arbeitsmedizin
| | - C Brendler
- Bundesanstalt für Arbeitsschutz und Arbeitsmedizin
| |
Collapse
|
7
|
Müller C, Sauter M, Barthelme J, Brendler C, Liebers F. Assoziation zwischen Manuellen Arbeitsprozessen und Schmerzen im Bereich der Hände in der BIBB/BAuA-Erwerbstätigenbefragung 2018. Das Gesundheitswesen 2021. [DOI: 10.1055/s-0041-1732160] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- C Müller
- Bundesanstalt für Arbeitsschutz und Arbeitsmedizin
| | - M Sauter
- Bundesanstalt für Arbeitsschutz und Arbeitsmedizin
| | - J Barthelme
- Bundesanstalt für Arbeitsschutz und Arbeitsmedizin
| | - C Brendler
- Bundesanstalt für Arbeitsschutz und Arbeitsmedizin
| | - F Liebers
- Bundesanstalt für Arbeitsschutz und Arbeitsmedizin
| |
Collapse
|
8
|
Abstract
BACKGROUND The quality of trauma care in Germany has been significantly increased due to the establishment of standards in the white paper on severe injury care and the S3 guidelines. A key issue of multiple trauma treatment is the trauma resuscitation unit (TRU)/emergency room management, which is associated with extensive material and human resources. From the very beginning of the introduction of structured care for the severely injured, the choice of the target hospital and the indications for TRU have been the focus of scientific research. Furthermore, a reduction of the TRU team for presumably less seriously injured patients is discussed. MATERIAL AND METHODS The emergency room assignments of a level I trauma center (n = 686) were analyzed in more detail. Of the patients 235 were assigned with the TRU indications according to the cause of the accident (GoR B criteria) and compared with the collective of TRU patients admitted according to the severity of injuries or life-threatening signs, the so-called GoR A criteria (n = 104) during the corresponding period. In addition to basic data (age, sex), the injured region and severity (injury severity score, ISS), the length of stay in the intensive care unit (ICU) and hospital as well as the necessity for surgery and transfusion were compared. RESULT Of the emergency room allocations at the trauma center 34% were due to the cause of the accident and the severity of the injuries in this patient group was almost half as high as that of the control group with an ISS of 11. Of the patients 74% were admitted to the IMC/ICU and stayed there for an average of almost 3 days. There were between 4% and 18% severe injuries (abbreviated injury scale, AIS 3) and 17.9% were characterized as polytrauma with an ISS ≥ 16 points. CONCLUSION A significant number of patients admitted to a TCU due to the cause of accident (the so-called B criteria of the white book), have severe and potentially life-threatening injuries, which necessitate a prioritized and immediate treatment by a TCU team. Whether a reduced TCU team is sufficient in this situation needs to be critically examined.
Collapse
Affiliation(s)
- U Schweigkofler
- Abteilung für Unfallchirurgie und orthopädische Chirurgie, Berufsgenossenschaftliche Unfallklinik Frankfurt am Main, Friedberger Landstraße 430, 60389, Frankfurt, Deutschland.
| | - M Sauter
- Abteilung für Unfallchirurgie und orthopädische Chirurgie, Berufsgenossenschaftliche Unfallklinik Frankfurt am Main, Friedberger Landstraße 430, 60389, Frankfurt, Deutschland
| | - D Wincheringer
- Abteilung für Unfallchirurgie und orthopädische Chirurgie, Berufsgenossenschaftliche Unfallklinik Frankfurt am Main, Friedberger Landstraße 430, 60389, Frankfurt, Deutschland
| | - S Barzen
- Abteilung für Unfallchirurgie und orthopädische Chirurgie, Berufsgenossenschaftliche Unfallklinik Frankfurt am Main, Friedberger Landstraße 430, 60389, Frankfurt, Deutschland
| | - R Hoffmann
- Abteilung für Unfallchirurgie und orthopädische Chirurgie, Berufsgenossenschaftliche Unfallklinik Frankfurt am Main, Friedberger Landstraße 430, 60389, Frankfurt, Deutschland
| |
Collapse
|
9
|
Uhl P, Grundmann C, Sauter M, Storck P, Tursch A, Özbek S, Leotta K, Roth R, Witzigmann D, Kulkarni JA, Fidelj V, Kleist C, Cullis PR, Fricker G, Mier W. Coating of PLA-nanoparticles with cyclic, arginine-rich cell penetrating peptides enables oral delivery of liraglutide. Nanomedicine 2019; 24:102132. [PMID: 31783138 DOI: 10.1016/j.nano.2019.102132] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/08/2019] [Revised: 09/20/2019] [Accepted: 11/17/2019] [Indexed: 12/31/2022]
Abstract
Until today, the oral delivery of peptide drugs is hampered due to their instability in the gastrointestinal tract and low mucosal penetration. To overcome these hurdles, PLA (polylactide acid)-nanoparticles were coated with a cyclic, polyarginine-rich, cell penetrating peptide (cyclic R9-CPP). These surface-modified nanoparticles showed a size and polydispersity index comparable to standard PLA-nanoparticles. The zeta potential showed a significant increase indicating successful CPP-coupling to the surface of the nanoparticles. Cryo-EM micrographs confirmed the appropriate size and morphology of the modified nanoparticles. A high encapsulation efficiency of liraglutide could be achieved. In vitro tests using Caco-2 cells showed high viability indicating the tolerability of this novel formulation. A strongly enhanced mucosal binding and penetration was demonstrated by a Caco-2 binding and uptake assay. In Wistar rats, the novel nanoparticles showed a substantial, 4.5-fold increase in the oral bioavailability of liraglutide revealing great potential for the oral delivery of peptide drugs.
Collapse
Affiliation(s)
- P Uhl
- Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany
| | - C Grundmann
- Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany
| | - M Sauter
- Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany; Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany
| | - P Storck
- Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany
| | - A Tursch
- University of Heidelberg, Centre for Organismal Studies, Department of Molecular Evolution and Genomics, Heidelberg, Germany
| | - S Özbek
- University of Heidelberg, Centre for Organismal Studies, Department of Molecular Evolution and Genomics, Heidelberg, Germany
| | - K Leotta
- Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany
| | - R Roth
- Division of Pharmaceutical Technology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
| | - D Witzigmann
- Division of Pharmaceutical Technology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland; Department of Biochemistry and Molecular Biology, University of British Columbia, Health Sciences Mall, Vancouver, British Columbia, Canada
| | - J A Kulkarni
- Department of Biochemistry and Molecular Biology, University of British Columbia, Health Sciences Mall, Vancouver, British Columbia, Canada
| | - V Fidelj
- Institute of Pharmacy and Molecular Biotechnology, Department of Pharmaceutical Technology and Biopharmacy, Ruprecht-Karls University, Heidelberg, Germany
| | - C Kleist
- Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany
| | - P R Cullis
- Department of Biochemistry and Molecular Biology, University of British Columbia, Health Sciences Mall, Vancouver, British Columbia, Canada
| | - G Fricker
- Institute of Pharmacy and Molecular Biotechnology, Department of Pharmaceutical Technology and Biopharmacy, Ruprecht-Karls University, Heidelberg, Germany
| | - W Mier
- Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany.
| |
Collapse
|
10
|
Eysholdt‐Derzsó E, Sauter M. Hypoxia and the group VII ethylene response transcription factor HRE2 promote adventitious root elongation in Arabidopsis. Plant Biol (Stuttg) 2019; 21 Suppl 1:103-108. [PMID: 29996004 PMCID: PMC6585952 DOI: 10.1111/plb.12873] [Citation(s) in RCA: 31] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/08/2018] [Accepted: 07/09/2018] [Indexed: 05/17/2023]
Abstract
Soil water-logging and flooding are common environmental stress conditions that can impair plant fitness. Roots are the first organs to be confronted with reduced oxygen tension as a result of flooding. While anatomical and morphological adaptations of roots are extensively studied, the root system architecture is only now becoming a focus of flooding research. Adventitious root (AR) formation shifts the root system higher up the plant, thereby facilitating supply with oxygen, and thus improving root and plant survival. We used Arabidopsis knockout mutants and overexpressors of ERFVII transcription factors to study their role in AR formation under hypoxic conditions and in response to ethylene. Results show that ethylene inhibits AR formation. Hypoxia mainly promotes AR elongation rather than formation mediated by ERFVII transcription factors, as indicated by reduced AR elongation in erfVII seedlings. Overexpression of HRE2 induces AR elongation to the same degree as hypoxia, while ethylene overrides HRE2-induced AR elongation. The ERFVII transcription factors promote establishment of an AR system that is under negative control by ethylene. Inhibition of growth of the main root system and promotion of AR elongation under hypoxia strengthens the root system in upper soil layers where oxygen shortage may last for shorter time periods.
Collapse
Affiliation(s)
- E. Eysholdt‐Derzsó
- Plant Developmental Biology and Plant PhysiologyUniversity of KielKielGermany
| | - M. Sauter
- Plant Developmental Biology and Plant PhysiologyUniversity of KielKielGermany
| |
Collapse
|
11
|
Klingel K, Sauter M, Milla J, Bundschuh S, Manuylova T. P4528Discrimination of infectious and non-infectious acute and chronic myocarditis in children and adults by endomyocardial biopsies. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.p4528] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- K Klingel
- University Hospital Tuebingen, Cardiopathology, Institute for Pathology and Neuropathology, Tuebingen, Germany
| | - M Sauter
- University Hospital Tuebingen, Cardiopathology, Institute for Pathology and Neuropathology, Tuebingen, Germany
| | - J Milla
- University Hospital Tuebingen, Cardiopathology, Institute for Pathology and Neuropathology, Tuebingen, Germany
| | - S Bundschuh
- University Hospital Tuebingen, Cardiopathology, Institute for Pathology and Neuropathology, Tuebingen, Germany
| | - T Manuylova
- University Hospital Tuebingen, Cardiopathology, Institute for Pathology and Neuropathology, Tuebingen, Germany
| |
Collapse
|
12
|
Andreev V, Baghdasaryan A, Begzsuren K, Belousov A, Bertone V, Bolz A, Boudry V, Brandt G, Brisson V, Britzger D, Buniatyan A, Bylinkin A, Bystritskaya L, Campbell AJ, Cantun Avila KB, Cerny K, Chekelian V, Contreras JG, Cvach J, Currie J, Dainton JB, Daum K, Diaconu C, Dobre M, Dodonov V, Eckerlin G, Egli S, Elsen E, Favart L, Fedotov A, Feltesse J, Fleischer M, Fomenko A, Gabathuler E, Gayler J, Gehrmann T, Ghazaryan S, Goerlich L, Gogitidze N, Gouzevitch M, Grab C, Grebenyuk A, Greenshaw T, Grindhammer G, Gwenlan C, Haidt D, Henderson RCW, Hladkỳ J, Hoffmann D, Horisberger R, Hreus T, Huber F, Huss A, Jacquet M, Janssen X, Jung AW, Jung H, Kapichine M, Katzy J, Kiesling C, Klein M, Kleinwort C, Kogler R, Kostka P, Kretzschmar J, Krücker D, Krüger K, Landon MPJ, Lange W, Laycock P, Lebedev A, Levonian S, Lipka K, List B, List J, Lobodzinski B, Malinovski E, Martyn HU, Maxfield SJ, Mehta A, Meyer AB, Meyer H, Meyer J, Mikocki S, Morozov A, Müller K, Naumann T, Newman PR, Niebuhr C, Niehues J, Nowak G, Olsson JE, Ozerov D, Pascaud C, Patel GD, Perez E, Petrukhin A, Picuric I, Pirumov H, Pitzl D, Plačakytė R, Polifka R, Rabbertz K, Radescu V, Raicevic N, Ravdandorj T, Reimer P, Rizvi E, Robmann P, Roosen R, Rostovtsev A, Rotaru M, Šálek D, Sankey DPC, Sauter M, Sauvan E, Schmitt S, Schoeffel L, Schöning A, Sefkow F, Shushkevich S, Soloviev Y, Sopicki P, South D, Spaskov V, Specka A, Steder M, Stella B, Straumann U, Sutton MR, Sykora T, Thompson PD, Traynor D, Truöl P, Tsakov I, Tseepeldorj B, Valkárová A, Vallée C, Van Mechelen P, Vazdik Y, Wegener D, Wünsch E, Žáček J, Zhang Z, Žlebčík R, Zohrabyan H, Zomer F. Determination of the strong coupling constant α s ( m Z ) in next-to-next-to-leading order QCD using H1 jet cross section measurements: H1 Collaboration. Eur Phys J C Part Fields 2017; 77:791. [PMID: 31997933 PMCID: PMC6956906 DOI: 10.1140/epjc/s10052-017-5314-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/22/2017] [Accepted: 10/12/2017] [Indexed: 06/08/2023]
Abstract
The strong coupling constant α s is determined from inclusive jet and dijet cross sections in neutral-current deep-inelastic ep scattering (DIS) measured at HERA by the H1 collaboration using next-to-next-to-leading order (NNLO) QCD predictions. The dependence of the NNLO predictions and of the resulting value ofα s ( m Z ) at the Z-boson mass m Z are studied as a function of the choice of the renormalisation and factorisation scales. Using inclusive jet and dijet data together, the strong coupling constant is determined to beα s ( m Z ) = 0.1157 ( 20 ) exp ( 29 ) th . Complementary,α s ( m Z ) is determined together with parton distribution functions of the proton (PDFs) from jet and inclusive DIS data measured by the H1 experiment. The valueα s ( m Z ) = 0.1142 ( 28 ) tot obtained is consistent with the determination from jet data alone. The impact of the jet data on the PDFs is studied. The running of the strong coupling is tested at different values of the renormalisation scale and the results are found to be in agreement with expectations.
Collapse
Affiliation(s)
- V. Andreev
- Lebedev Physical Institute, Moscow, Russia
| | | | - K. Begzsuren
- Institute of Physics and Technology of the Mongolian Academy of Sciences, Ulaanbaatar, Mongolia
| | | | - V. Bertone
- Department of Physics and Astronomy, Vrije University, De Boelelaan 1081, Amsterdam, The Netherlands
- National Institute for Subatomic Physics (NIKHEF), Science Park 105, Amsterdam, The Netherlands
| | - A. Bolz
- Physikalisches Institut, Universität Heidelberg, Heidelberg, Germany
| | - V. Boudry
- LLR, Ecole Polytechnique, CNRS/IN2P3, Palaiseau, France
| | - G. Brandt
- II. Physikalisches Institut, Universität Göttingen, Göttingen, Germany
| | - V. Brisson
- LAL, Université Paris-Sud, CNRS/IN2P3, Orsay, France
| | - D. Britzger
- Physikalisches Institut, Universität Heidelberg, Heidelberg, Germany
| | - A. Buniatyan
- School of Physics and Astronomy, University of Birmingham, Birmingham, UK
| | - A. Bylinkin
- Moscow Institute of Physics and Technology, Dolgoprudny, Moscow Region Russian Federation
| | - L. Bystritskaya
- Institute for Theoretical and Experimental Physics, Moscow, Russia
| | | | | | - K. Cerny
- Faculty of Mathematics and Physics, Charles University, Prague, Czech Republic
| | | | - J. G. Contreras
- Departamento de Fisica Aplicada, CINVESTAV, Mérida, Yucatán Mexico
| | - J. Cvach
- Institute of Physics, Academy of Sciences of the Czech Republic, Prague, Czech Republic
| | - J. Currie
- Institute for Particle Physics Phenomenology, Ogden Centre for Fundamental Physics, Durham University, South Road, Durham, UK
| | - J. B. Dainton
- Department of Physics, University of Liverpool, Liverpool, UK
| | - K. Daum
- Fachbereich C, Universität Wuppertal, Wuppertal, Germany
| | - C. Diaconu
- Aix Marseille Université, CNRS/IN2P3, CPPM UMR 7346, 13288 Marseille, France
| | - M. Dobre
- Horia Hulubei National Institute for R&D in Physics and Nuclear Engineering (IFIN-HH), Bucharest, Romania
| | | | | | - S. Egli
- Paul Scherrer Institute, Villigen, Switzerland
| | | | - L. Favart
- Inter-University Institute for High Energies ULB-VUB, Brussels and Universiteit Antwerpen, Antwerp, Belgium
| | - A. Fedotov
- Institute for Theoretical and Experimental Physics, Moscow, Russia
| | | | | | - A. Fomenko
- Lebedev Physical Institute, Moscow, Russia
| | - E. Gabathuler
- Department of Physics, University of Liverpool, Liverpool, UK
| | | | - T. Gehrmann
- Physik-Institut der Universität Zürich, Zurich, Switzerland
| | | | - L. Goerlich
- Institute of Nuclear Physics, Polish Academy of Sciences, 31342 Kraków, Poland
| | | | - M. Gouzevitch
- IPNL, Université Claude Bernard Lyon 1, CNRS/IN2P3, Villeurbanne, France
| | - C. Grab
- Institut für Teilchenphysik, ETH Zürich, Zurich, Switzerland
| | - A. Grebenyuk
- Inter-University Institute for High Energies ULB-VUB, Brussels and Universiteit Antwerpen, Antwerp, Belgium
| | - T. Greenshaw
- Department of Physics, University of Liverpool, Liverpool, UK
| | | | - C. Gwenlan
- Department of Physics, Oxford University, Oxford, UK
| | | | | | - J. Hladkỳ
- Institute of Physics, Academy of Sciences of the Czech Republic, Prague, Czech Republic
| | - D. Hoffmann
- Aix Marseille Université, CNRS/IN2P3, CPPM UMR 7346, 13288 Marseille, France
| | | | - T. Hreus
- Inter-University Institute for High Energies ULB-VUB, Brussels and Universiteit Antwerpen, Antwerp, Belgium
| | - F. Huber
- Physikalisches Institut, Universität Heidelberg, Heidelberg, Germany
| | - A. Huss
- Institut für Teilchenphysik, ETH Zürich, Zurich, Switzerland
| | - M. Jacquet
- LAL, Université Paris-Sud, CNRS/IN2P3, Orsay, France
| | - X. Janssen
- Inter-University Institute for High Energies ULB-VUB, Brussels and Universiteit Antwerpen, Antwerp, Belgium
| | - A. W. Jung
- Department of Physics and Astronomy, Purdue University, 525 Northwestern Ave, West Lafayette, IN 47907 USA
| | | | - M. Kapichine
- Joint Institute for Nuclear Research, Dubna, Russia
| | | | - C. Kiesling
- Max-Planck-Institut für Physik, Munich, Germany
| | - M. Klein
- Department of Physics, University of Liverpool, Liverpool, UK
| | | | - R. Kogler
- Institut für Experimentalphysik, Universität Hamburg, Hamburg, Germany
| | - P. Kostka
- Department of Physics, University of Liverpool, Liverpool, UK
| | - J. Kretzschmar
- Department of Physics, University of Liverpool, Liverpool, UK
| | | | | | - M. P. J. Landon
- School of Physics and Astronomy, Queen Mary University of London, London, UK
| | | | - P. Laycock
- Department of Physics, University of Liverpool, Liverpool, UK
| | - A. Lebedev
- Lebedev Physical Institute, Moscow, Russia
| | | | | | | | | | | | | | - H.-U. Martyn
- I. Physikalisches Institut der RWTH, Aachen, Germany
| | - S. J. Maxfield
- Department of Physics, University of Liverpool, Liverpool, UK
| | - A. Mehta
- Department of Physics, University of Liverpool, Liverpool, UK
| | | | - H. Meyer
- Fachbereich C, Universität Wuppertal, Wuppertal, Germany
| | | | - S. Mikocki
- Institute of Nuclear Physics, Polish Academy of Sciences, 31342 Kraków, Poland
| | - A. Morozov
- Joint Institute for Nuclear Research, Dubna, Russia
| | - K. Müller
- Physik-Institut der Universität Zürich, Zurich, Switzerland
| | | | - P. R. Newman
- School of Physics and Astronomy, University of Birmingham, Birmingham, UK
| | | | - J. Niehues
- Physik-Institut der Universität Zürich, Zurich, Switzerland
| | - G. Nowak
- Institute of Nuclear Physics, Polish Academy of Sciences, 31342 Kraków, Poland
| | | | - D. Ozerov
- Paul Scherrer Institute, Villigen, Switzerland
| | - C. Pascaud
- LAL, Université Paris-Sud, CNRS/IN2P3, Orsay, France
| | - G. D. Patel
- Department of Physics, University of Liverpool, Liverpool, UK
| | | | - A. Petrukhin
- IPNL, Université Claude Bernard Lyon 1, CNRS/IN2P3, Villeurbanne, France
| | - I. Picuric
- Faculty of Science, University of Montenegro, Podgorica, Montenegro
| | | | | | | | - R. Polifka
- Faculty of Mathematics and Physics, Charles University, Prague, Czech Republic
- Department of Physics, University of Toronto, Toronto, ON M5S 1A7 Canada
| | - K. Rabbertz
- Karlsruher Institut für Technologie (KIT), Institut für Experimentelle Teilchenphysik (ETP), Wolfgang-Gaede-Str. 1, Karlsruhe, Germany
| | - V. Radescu
- Department of Physics, Oxford University, Oxford, UK
| | - N. Raicevic
- Faculty of Science, University of Montenegro, Podgorica, Montenegro
| | - T. Ravdandorj
- Institute of Physics and Technology of the Mongolian Academy of Sciences, Ulaanbaatar, Mongolia
| | - P. Reimer
- Institute of Physics, Academy of Sciences of the Czech Republic, Prague, Czech Republic
| | - E. Rizvi
- School of Physics and Astronomy, Queen Mary University of London, London, UK
| | - P. Robmann
- Physik-Institut der Universität Zürich, Zurich, Switzerland
| | - R. Roosen
- Inter-University Institute for High Energies ULB-VUB, Brussels and Universiteit Antwerpen, Antwerp, Belgium
| | - A. Rostovtsev
- Institute for Information Transmission Problems RAS, Moscow, Russia
| | - M. Rotaru
- Horia Hulubei National Institute for R&D in Physics and Nuclear Engineering (IFIN-HH), Bucharest, Romania
| | - D. Šálek
- Faculty of Mathematics and Physics, Charles University, Prague, Czech Republic
| | - D. P. C. Sankey
- STFC, Rutherford Appleton Laboratory, Didcot, Oxfordshire UK
| | - M. Sauter
- Physikalisches Institut, Universität Heidelberg, Heidelberg, Germany
| | - E. Sauvan
- Aix Marseille Université, CNRS/IN2P3, CPPM UMR 7346, 13288 Marseille, France
- LAPP, Université de Savoie, CNRS/IN2P3, Annecy-le-Vieux, France
| | | | | | - A. Schöning
- Physikalisches Institut, Universität Heidelberg, Heidelberg, Germany
| | | | - S. Shushkevich
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, Moscow, Russia
| | | | - P. Sopicki
- Institute of Nuclear Physics, Polish Academy of Sciences, 31342 Kraków, Poland
| | | | - V. Spaskov
- Joint Institute for Nuclear Research, Dubna, Russia
| | - A. Specka
- LLR, Ecole Polytechnique, CNRS/IN2P3, Palaiseau, France
| | | | - B. Stella
- Dipartimento di Fisica, Università di Roma Tre and INFN Roma 3, Rome, Italy
| | - U. Straumann
- Physik-Institut der Universität Zürich, Zurich, Switzerland
| | - M. R. Sutton
- Department of Physics and Astronomy, University of Sussex, Pevensey II, Brighton, UK
| | - T. Sykora
- Inter-University Institute for High Energies ULB-VUB, Brussels and Universiteit Antwerpen, Antwerp, Belgium
- Faculty of Mathematics and Physics, Charles University, Prague, Czech Republic
| | - P. D. Thompson
- School of Physics and Astronomy, University of Birmingham, Birmingham, UK
| | - D. Traynor
- School of Physics and Astronomy, Queen Mary University of London, London, UK
| | - P. Truöl
- Physik-Institut der Universität Zürich, Zurich, Switzerland
| | - I. Tsakov
- Institute for Nuclear Research and Nuclear Energy, Sofia, Bulgaria
| | - B. Tseepeldorj
- Institute of Physics and Technology of the Mongolian Academy of Sciences, Ulaanbaatar, Mongolia
- Ulaanbaatar University, Ulaanbaatar, Mongolia
| | - A. Valkárová
- Faculty of Mathematics and Physics, Charles University, Prague, Czech Republic
| | - C. Vallée
- Aix Marseille Université, CNRS/IN2P3, CPPM UMR 7346, 13288 Marseille, France
| | - P. Van Mechelen
- Inter-University Institute for High Energies ULB-VUB, Brussels and Universiteit Antwerpen, Antwerp, Belgium
| | - Y. Vazdik
- Lebedev Physical Institute, Moscow, Russia
| | - D. Wegener
- Institut für Physik, TU Dortmund, Dortmund, Germany
| | | | - J. Žáček
- Faculty of Mathematics and Physics, Charles University, Prague, Czech Republic
| | - Z. Zhang
- LAL, Université Paris-Sud, CNRS/IN2P3, Orsay, France
| | | | | | - F. Zomer
- LAL, Université Paris-Sud, CNRS/IN2P3, Orsay, France
| |
Collapse
|
13
|
Shomanova Z, Florian A, Sauter M, Roesch S, Sechtem U, Klingel K, Yilmaz A. P3512Disruption of the sarcoglycan-dystrophin complex in patients with biopsy-proven myocarditis - novel pathophysiological insights based on comprehensive analyses of endomyocardial biopsies. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx504.p3512] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
14
|
|
15
|
Gläser D, Dell’Oca A, Tatomir A, Bensabat J, Class H, Guadagnini A, Helmig R, McDermott C, Riva M, Sauter M. An Approach Towards a FEP-based Model for Risk Assessment for Hydraulic Fracturing Operations. ACTA ACUST UNITED AC 2016. [DOI: 10.1016/j.egypro.2016.10.030] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
16
|
Abstract
We report the case of a patient with suspected ulcerating necrotizing herpetic stromal keratitis who showed no improvement despite intensive (amongst others antiherpetic) topical and systemic therapy. The ulcer healed following amniotic membrane transplantation and penetrating excimer laser keratoplasty was performed to improve visual acuity. The excision showed deep stromal proof of herpes simplex virus (HSV) type 1 antigens.
Collapse
Affiliation(s)
- C Spira
- Klinik für Augenheilkunde, Universitätsklinikum des Saarlandes UKS, Kirrberger Str. 100, Gebäude 22, 66424, Homburg/Saar, Deutschland,
| | | | | | | | | | | |
Collapse
|
17
|
Bissler J, Kingswood J, Radzikowska E, Zonnenberg B, Frost M, Belousova E, Sauter M, Nonomura N, Brakemeier S, De Vries P, Berkowitz N, Peyrard S, Budde K. 1 Everolimus for renal angiomyolipoma associated with tuberous sclerosis complex (TSC) from EXIST-2: Continued efficacy and diminishing adverse events after ∼3.5 years of treatment. ACTA ACUST UNITED AC 2015. [DOI: 10.1016/s1569-9056(15)60004-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
18
|
Fox MR, Pandolfino JE, Sweis R, Sauter M, Abreu Y Abreu AT, Anggiansah A, Bogte A, Bredenoord AJ, Dengler W, Elvevi A, Fruehauf H, Gellersen S, Ghosh S, Gyawali CP, Heinrich H, Hemmink M, Jafari J, Kaufman E, Kessing K, Kwiatek M, Lubomyr B, Banasiuk M, Mion F, Pérez-de-la-Serna J, Remes-Troche JM, Rohof W, Roman S, Ruiz-de-León A, Tutuian R, Uscinowicz M, Valdovinos MA, Vardar R, Velosa M, Waśko-Czopnik D, Weijenborg P, Wilshire C, Wright J, Zerbib F, Menne D. Inter-observer agreement for diagnostic classification of esophageal motility disorders defined in high-resolution manometry. Dis Esophagus 2014; 28:711-9. [PMID: 25185507 DOI: 10.1111/dote.12278] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
High-resolution esophageal manometry (HRM) is a recent development used in the evaluation of esophageal function. Our aim was to assess the inter-observer agreement for diagnosis of esophageal motility disorders using this technology. Practitioners registered on the HRM Working Group website were invited to review and classify (i) 147 individual water swallows and (ii) 40 diagnostic studies comprising 10 swallows using a drop-down menu that followed the Chicago Classification system. Data were presented using a standardized format with pressure contours without a summary of HRM metrics. The sequence of swallows was fixed for each user but randomized between users to avoid sequence bias. Participants were blinded to other entries. (i) Individual swallows were assessed by 18 practitioners (13 institutions). Consensus agreement (≤ 2/18 dissenters) was present for most cases of normal peristalsis and achalasia but not for cases of peristaltic dysmotility. (ii) Diagnostic studies were assessed by 36 practitioners (28 institutions). Overall inter-observer agreement was 'moderate' (kappa 0.51) being 'substantial' (kappa > 0.7) for achalasia type I/II and no lower than 'fair-moderate' (kappa >0.34) for any diagnosis. Overall agreement was somewhat higher among those that had performed >400 studies (n = 9; kappa 0.55) and 'substantial' among experts involved in development of the Chicago Classification system (n = 4; kappa 0.66). This prospective, randomized, and blinded study reports an acceptable level of inter-observer agreement for HRM diagnoses across the full spectrum of esophageal motility disorders for a large group of clinicians working in a range of medical institutions. Suboptimal agreement for diagnosis of peristaltic motility disorders highlights contribution of objective HRM metrics.
Collapse
Affiliation(s)
- M R Fox
- iDigest: Zürich Center for Reflux and Swallowing Disorders, Division of Gastroenterology and Hepatology, University Hospital of Zurich, Zurich, Switzerland.,NIHR Nottingham Digestive Disease Biomedical Research Centre, Nottingham University Hospital
| | - J E Pandolfino
- Department of Gastroenterology, Northwestern University School of Medicine, Chicago, Illinois, USA
| | - R Sweis
- Esophageal Laboratory, Guys and St. Thomas NHS Foundation Trust, London, UK
| | - M Sauter
- iDigest: Zürich Center for Reflux and Swallowing Disorders, Division of Gastroenterology and Hepatology, University Hospital of Zurich, Zurich, Switzerland
| | - A T Abreu Y Abreu
- Clínica de Fisiología Digestiva, Hospital Ángeles del Pedregal, Mexico City, Mexico
| | - A Anggiansah
- Esophageal Laboratory, Guys and St. Thomas NHS Foundation Trust, London, UK
| | - A Bogte
- Department of Gastroenterology and Hepatology, University Medical Center, Utrecht, The Netherlands
| | - A J Bredenoord
- Academic Medical Center Amsterdam, Amsterdam, The Netherlands
| | - W Dengler
- Legato Medical Systems, Inc., Rocky Mount, North Carolina, USA
| | - A Elvevi
- Ospedale Maggiore Policlinic, University of Milan, Milan, Italy
| | - H Fruehauf
- iDigest: Zürich Center for Reflux and Swallowing Disorders, Division of Gastroenterology and Hepatology, University Hospital of Zurich, Zurich, Switzerland
| | - S Gellersen
- Department of Surgery, St. Antonius Hospital, Cologne, Germany
| | - S Ghosh
- Global Health Economics and Market Access, Johnson & Johnson, Cincinnati, Ohio, USA
| | - C P Gyawali
- Division of Gastroenterology, Washington University School of Medicine, St. Louis, Missouri, USA
| | - H Heinrich
- iDigest: Zürich Center for Reflux and Swallowing Disorders, Division of Gastroenterology and Hepatology, University Hospital of Zurich, Zurich, Switzerland
| | - M Hemmink
- Department of Gastroenterology and Hepatology, St. Antonius Hospital, Nieuwegein, The Netherlands
| | - J Jafari
- Wingate Institute, Centre for Digestive Diseases, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
| | - E Kaufman
- iDigest: Zürich Center for Reflux and Swallowing Disorders, Division of Gastroenterology and Hepatology, University Hospital of Zurich, Zurich, Switzerland
| | - K Kessing
- Academic Medical Center Amsterdam, Amsterdam, The Netherlands
| | - M Kwiatek
- Department of Gastroenterology, Northwestern University School of Medicine, Chicago, Illinois, USA
| | - B Lubomyr
- Department of Gastroenterology, Northwestern University School of Medicine, Chicago, Illinois, USA
| | - M Banasiuk
- Department of Pediatric Gastroenterology, Medical University of Warsaw, Warsaw, Poland
| | - F Mion
- Digestive Physiology, Hospices Civils de Lyon and Lyon University, Lyon, France
| | | | - J M Remes-Troche
- Medical Biological Research Institute, University of Veracruz, México DF, Mexico
| | - W Rohof
- Academic Medical Center Amsterdam, Amsterdam, The Netherlands
| | - S Roman
- Digestive Physiology, Hospices Civils de Lyon and Lyon University, Lyon, France
| | - A Ruiz-de-León
- Department of Gastroenterology, Hospital Clínico San Carlos, Madrid, Spain
| | - R Tutuian
- University Clinics of Visceral Surgery and Medicine, Division of Gastroenterology, Bern University Hospital, Bern, Switzerland
| | - M Uscinowicz
- Department of Pediatrics, Gastroenterology and Allergology, Medical University of Bialystok, Bialystok, Poland
| | - M A Valdovinos
- Departamento de Gastroenterología and motility Laboratory Salvador Zubirán, Instituto Nacional de Ciencias Médicas y Nutrición, México DF, Mexico
| | - R Vardar
- Sect Gastroenterology & Ege Reflux Study Group, Ege University School of Medicine, Izmir, Turkey
| | - M Velosa
- Hospital Vila Franca de Xira, Vila Franca de Xira, Portugal
| | - D Waśko-Czopnik
- Department of Gastroenterology and Hepatology, Wroclaw Medical University, Wroclaw, Poland
| | - P Weijenborg
- Academic Medical Center Amsterdam, Amsterdam, The Netherlands
| | - C Wilshire
- Department of Surgery, University of Rochester, Rochester, New York, USA
| | - J Wright
- Division of Gastroenterology, University Hospital, Nottingham, UK
| | - F Zerbib
- Gastroenterology and Hepatology Department, CHU Bordeaux and Bordeaux Segalen University, Saint André Hospital, Bordeaux, France
| | - D Menne
- Menne Biomed, Tübingen, Germany
| |
Collapse
|
19
|
Sauter M, Berger F, Fischereder M. [Nephrotic syndrome in a woman with tuberous sclerosis]. Dtsch Med Wochenschr 2014; 139:1046-50. [PMID: 24801299 DOI: 10.1055/s-0034-1370024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
HISTORY AND CLINICAL FINDINGS A 50-year-old woman with known tuberous sclerosis complex (TSC) was referred for further work-up of nephrotic syndrome. A left-side nephrectomy due to an anamnestically reported "shrunken kidney" had been performed at the age of 15 years. The patient presented with massive edematous swelling of all extremities and typical cutaneous lesions of TSC. DIAGNOSTIC FINDINGS, TREATMENT AND CLINICAL COURSE: Laboratory analysis revealed nephrotic proteinuria, hypalbuminemia and advanced impairment of kidney function. Computed tomography revealed a massively enlarged remaining kidney with confluent angiomyolipomata. As kidney biopsy was deemed to be too hazardous, a thorough work-up for potentially underlying diseases finally revealed endometrial carcinoma. Hysterectomy resulted in a prompt and sustained decrease of proteinuria and disappearance of edema. CONCLUSION Although a renal involvement is typical in TSC the occurrence of nephrotic syndrome is not and should give reason for further evaluation.
Collapse
Affiliation(s)
- M Sauter
- Nephrologisches Zentrum, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München
| | - F Berger
- Institut für klinische Radiologie, Klinikum der Universität München
| | - M Fischereder
- Nephrologisches Zentrum, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München
| |
Collapse
|
20
|
Sauter M, Heinrich H, Fox M, Misselwitz B, Halama M, Schwizer W, Fried M, Fruehauf H. Toward more accurate measurements of anorectal motor and sensory function in routine clinical practice: validation of high-resolution anorectal manometry and Rapid Barostat Bag measurements of rectal function. Neurogastroenterol Motil 2014; 26:685-95. [PMID: 24517865 DOI: 10.1111/nmo.12317] [Citation(s) in RCA: 47] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/26/2013] [Accepted: 01/16/2014] [Indexed: 02/08/2023]
Abstract
BACKGROUND Measurements of anorectal function using high-resolution anorectal manometry (HR-ARM) and rectal barostat technology provide more reliable results than standard ARM with an elastic balloon; however, HR-ARM results have not been compared to ARM and standard barostat protocols are impractical in routine clinical practice. The aim of this study was to validate HR-ARM against standard ARM and standard barostat against a novel Rapid Barostat Bag (RBB) measurement and elastic balloon measurements of rectal function. METHODS Twenty-six healthy volunteers (15 female, 11 male, 19-52 years) were studied. Measurements of anal function and simulated defecation were compared for 12-sensor HR-ARM and 6-sensor standard ARM using line plots from the same recording. Rectal capacity, compliance, and sensation (volume threshold) were measured by elastic balloon, standard barostat, and RBB methods using stepwise inflation of a 700-mL polyethylene bag to 40 mmHg distension by electronic barostat and handheld syringe monitored by sphygmo-manometer, respectively. Results are reported as mean ± SD. Bland-Altman plots and correlation coefficients (r) for measurements were calculated. KEY RESULTS There was excellent agreement between HR- and standard ARM measurements (r > 0.86, <25 mmHg difference) and between standard barostat and RBB measurements of rectal capacity (r = 0.97, <25 mL difference). Correlation coefficients of threshold volumes for initial perception, urgency and discomfort were 0.37, 0.71, and 0.95, respectively. No significant correlation was present with elastic balloon measurements. Time to complete studies was shorter for HR-ARM than standard ARM and for RBB than standard barostat in historical controls. CONCLUSIONS & INFERENCES HR-ARM with RBB measurements of anorectal function provides quick and reasonably accurate measurements of continence function suitable for use in routine clinical practice (ClinicalTrial.gov NCT01456442).
Collapse
Affiliation(s)
- M Sauter
- Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland; Department of Internal Medicine, Triemli Hospital, Zurich, Switzerland
| | | | | | | | | | | | | | | |
Collapse
|
21
|
Kottgen A, Sallustio F, Cox SN, Serino G, Pesce F, De Palma G, Falchi M, Schena FP, Schena FP, Serino G, Sallustio F, Pesce F, De Palma G, Cox SN, Lai KN, Leung JC, Papagianni A, Stangou M, Goumenos D, Gerolymos M, Takahashi K, Yuzawa Y, Maruyama S, Imai E, Karras A, Mami I, Schmitt C, Nochy D, Rabant M, Hertig A, Vincent M, Thervet E, Puy H, Pallet N, Zonnenberg B, Eijkemans MJC, Reijnders L, Khosrovani S, Magestro M, Bissler JJ, Kingswood JC, Zonnenberg BA, Frost M, Belousova E, Sauter M, Berkowitz N, Miao S, Segal S, Brechenmacher T, Budde K, Franz DN. GENETICS. Nephrol Dial Transplant 2014. [DOI: 10.1093/ndt/gfu128] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
22
|
Davids MR, Marais N, Jacobs J, Cohen E, Krause I, Goldberg E, Garty M, Krause I, Dursun B, Sahan Y, Tanriverdi H, Rota S, Uslu S, Senol H, Minutolo R, Gabbai FB, Agarwal R, Chiodini P, Borrelli S, Stanzione G, Nappi F, Bellizzi V, Conte G, De Nicola L, Van De Walle J, Johnson S, Fremeaux-Bacchi V, Ardissino G, Ariceta G, Beauchamp J, Cohen D, Greenbaum LA, Ogawa M, Schaefer F, Licht C, Scalzotto E, Nalesso F, Zaglia T, Corradi V, Neri M, Martino F, Zanella M, Brendolan A, Mongillo M, Ronco C, Chinnappa S, Mooney A, El Nahas AM, Tu YK, Tan LB, Jung JY, Kim AJ, Ro H, Lee C, Chang JH, Lee HH, Chung W, Clarke AL, Young HM, Hull KL, Hudson N, Burton JO, Smith AC, Marx S, Petrilla A, Filipovic I, Lee WC, Meijers B, Poesen R, Storr M, Claes K, Kuypers D, Evenepoel P, Aukland M, Clarke AL, Hull KL, Burton JO, Smith AC, Betriu A, Martinez-Alonso M, Arcidiacono MV, Cannata-Andia J, Pascual J, Valdivielso JM, Fernandez-Giraldez E, Kingswood JC, Zonnenberg B, Sauter M, Zakar G, Biro B, Besenczi B, Varga A, Pekacs P, Pizzini P, Pisano A, Leonardis D, Panuccio V, Cutrupi S, Tripepi G, Mallamaci F, Zoccali C, Arnold J, Baharani J, Rayner H, So BH, Blackwell S, Jardine AG, Macgregor MS, Cunha C, Barreto P, Pereira S, Ventura A, Mota M, Seabra J, Sakaguchi T, Kobayashi S, Yano T, Yoshimoto W, Bancu I, Bonal Bastons J, Cleries Escayola M, Vela Vallespin E, Bustins Poblet M, Magem Luque D, Pastor Fabregas M, Chen JH, Chen SC, Chang JM, Hwang SJ, Chen HC, Ahbap E, Kara E, Basturk T, Sahutoglu T, Koc Y, Sakaci T, Sevinc M, Akgol C, Ozagari AA, Unsal A, Minami S, Hesaka A, Yamaguchi S, Iwahashi E, Sakai S, Fujimoto T, Sasaki K, Fujita Y, Yokoyama K, Marks A, Fluck N, Prescott G, Robertson L, Smith WC, Black C, Ohsawa M, Fujioka T, Omori S, Isurugi T, Tanno K, Onoda T, Omama S, Ishibashi Y, Makita S, Okayama A, Garland JS, Simpson CS, Metangi MF, Parfrey B, Johri AM, Sloan L, McAuley J, Cunningham R, Mullan R, Quinn M, Harron C, Chiu H, Murphy-Burke D, Werb R, Jung B, Chan-Yan C, Duncan J, Forzley B, Lowry R, Hargrove G, Carson R, Levin A, Karim M, Reznik EV, Storozhakov GIV, Rollino C, Troiano M, Bagatella M, Liuzzo C, Quarello F, Roccatello D, Blaslov K, Bulum T, Prka In I, Duvnjak L, Heleniak Z, Ciepli ska M, Szychli ski T, Pryczkowska M, Bartosi ska E, Wiatr H, Kot owska H, Tylicki L, Rutkowski B, Song YR, Kim SGK, Kim HJ, Noh JW, Tong A, Jesudason S, Craig JC, Winkelmayer WC, Hung PH, Huang YT, Hsiao CY, Sung PS, Guo HR, Tsai KJ, Wu CC, Su SL, Kao SY, Lu KC, Lin YF, Lin WH, Lee HM, Cheng MF, Wang WM, Yang LY, Wang MC, Vukovic Lela I, Sekoranja M, Poljicanin T, Karanovic S, Abramovic M, Matijevic V, Stipancic Z, Leko N, Cvitkovic A, Dika Z, Kos J, Laganovic M, Grollman AP, Jelakovic B, Dryl-Rydzynska T, Prystacki T, Malyszko J, Trifiro G, Sultana J, Giorgianni F, Ingrasciotta Y, Muscianisi M, Tari DU, Perrotta M, Buemi M, Canale V, Arcoraci V, Santoro D, Rizzo M, Iheanacho I, Van Nooten FE, Goldsmith D, Grandtnerova B, Berat ova Z, ErvenOva M, cErven J, Markech M, tefanikova A, Engelen W, Elseviers M, Gheuens E, Colson C, Muyshondt I, Daelemans R. CKD GENERAL AND CLINICAL EPIDEMIOLOGY 2. Nephrol Dial Transplant 2014. [DOI: 10.1093/ndt/gfu167] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
23
|
Bissler J, Kingswood J, Radzikowska E, Zonnenberg B, Frost M, Belousova E, Sauter M, Nonomura N, Brakemeier S, De Vries P, Berkowitz N, Segal S, Anak O, Peyard S, Budde K. 1139 Everolimus for renal angiomyolipoma associated with tuberous sclerosis complex (TSC): EXIST-2 3-year follow-up. ACTA ACUST UNITED AC 2014. [DOI: 10.1016/s1569-9056(14)61119-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
24
|
Klingel K, Sauter M, Ettischer N, Kandolf R, Ursu O. Heme oxygenase-1 mediates ROS production and ongoing injury in CVB3 myocarditis. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht309.p3867] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
25
|
Brunner S, Theiss HD, Grabmaier U, Sauter M, Clevert A, Klingel K, Franz WM. Enhanced migration of bone marrow-derived cells mediated by VCAM-1/VLA-4 interaction improves cardiac function in virus-induced dilated cardiomyopathy. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht309.p4195] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
26
|
Jankowska M, Walerzak A, Debska-Slizien A, Rutkowski B, Frank V, Decker E, Bachmann N, Eisenberger T, Decker C, Bolz HJ, Bergmann C, Kurt B, Paliege A, Willam C, Schwarzensteiner I, Schucht K, Neymeyer H, Sequeira-Lopez MLS, Bachmann S, Gomez RA, Eckardt KU, Kurtz A, Bissler JJ, Zonnenberg B, Frost M, Radzikowska E, Sauter M, Nonomura N, de Vries P, Lam D, Miao S, Cauwel H, Kingswood JC. Cystic kidney diseases. Nephrol Dial Transplant 2013. [DOI: 10.1093/ndt/gft158] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
27
|
Heinrich H, Fruehauf H, Sauter M, Steingötter A, Fried M, Schwizer W, Fox M. The effect of standard compared to enhanced instruction and verbal feedback on anorectal manometry measurements. Neurogastroenterol Motil 2013; 25:230-7, e163. [PMID: 23130678 DOI: 10.1111/nmo.12038] [Citation(s) in RCA: 38] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
BACKGROUND Guidelines recommend instruction and motivation during anorectal manometry; however, its impact on findings has not been reported. This study assessed the effects of standard versus enhanced instruction and verbal feedback on the results of anorectal manometry. METHODS High-resolution manometry was performed by a solid-state catheter with 10 circumferential sensors at 6 mm separation across the anal canal and two rectal sensors. Measurements were acquired first with standard instruction and then with enhanced instruction and verbal feedback. On both occasions, squeeze pressure and duration during three voluntary contractions and intra-rectal pressure and recto-anal pressure gradient (RAPG) during three attempts at simulated defecation were assessed. KEY RESULTS A total of 70 consecutive patients (54 female; age 25-82 years) referred for investigation of fecal incontinence (n = 31), constipation, and related disorders of defecation (n = 39) were studied. Enhanced instruction and verbal feedback increased maximum squeeze pressure (Δ10 ± 28.5 mmHg; P < 0.0038) and duration of contraction (Δ3 ± 4 s; P < 0.0001). During simulated defecation, it increased intra-rectal pressure (Δ12 ± 14 mmHg; P < 0.003) and RAPG (Δ11 ± 20 mmHg; P < 0.0001). Using standard diagnostic criteria, the intervention changed manometric findings from locally validated 'pathologic' to 'normal' values in 14/31 patients with incontinence and 12/39 with disorders of defecation. CONCLUSIONS & INFERENCES Enhanced instruction and verbal feedback significantly improved voluntary anorectal functions and resulted in a clinically relevant change of manometric diagnosis in some patients. Effective explanation of procedures and motivation during manometry is required to ensure consistent results and to provide an accurate representation of patient ability to retain continence and evacuate stool.
Collapse
Affiliation(s)
- H Heinrich
- Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.
| | | | | | | | | | | | | |
Collapse
|
28
|
Sauter M, Curcic J, Menne D, Goetze O, Fried M, Schwizer W, Steingoetter A. Measuring the interaction of meal and gastric secretion: a combined quantitative magnetic resonance imaging and pharmacokinetic modeling approach. Neurogastroenterol Motil 2012; 24:632-8, e272-3. [PMID: 22452723 DOI: 10.1111/j.1365-2982.2012.01916.x] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
BACKGROUND The stimulation and intragastric accumulation of gastric secretion has been recognized as an important factor in gastroesophageal reflux disease. However, the interaction of gastric secretion and meal emptying has not been fully understood. Current methods to assess gastric secretion are either invasive or unable to provide information on its volume, distribution and dynamics. The aim of this study was to quantify the interaction between meal emptying and meal induced gastric secretion by using quantitative magnetic resonance imaging (MRI) and pharmacokinetic analysis. METHODS A chocolate test meal was developed which is secretion stimulating and MRI compatible. Meal emptying and gastric secretion were assessed in fourteen healthy volunteers using a validated quantitative MRI technique. A population based pharmacokinetic model was developed and applied to the extracted volume data, assessing the meal emptying rate, rate of secretion and their interaction. KEY RESULTS The test meal continuously induced gastric secretion in all subjects, which partly accumulated at the meal-air interface, forming a 'secretion layer' in the proximal stomach. Traditional fitting detected a significant correlation between meal emptying rate and rate of secretion. The pharmacokinetic model quantified this interaction and estimated a 2.3 ± 1 fold higher effect of meal on secretion than vice versa. The efficacy of the emptied meal to produce gastric secretion was 61%. CONCLUSIONS & INFERENCES The combined quantitative MRI and pharmacokinetic model approach allows for the quantification of gastric secretion volume and its interaction on meal emptying. The observed secretion layer might explain previous findings postulating the presence of an intragastric 'acid pocket'.
Collapse
Affiliation(s)
- M Sauter
- Division of Gastroenterology and Hepatology, University of Zurich, Zurich, Switzerland
| | | | | | | | | | | | | |
Collapse
|
29
|
Zonnenberg B, Budde K, Kingswood C, Frost M, Belousova E, Radzikowska E, Sauter M, Nonomura N, Brakemeier S, De Vries P, Klimovsky J, Shah G, Miao S, Lincy J, Bissler J, Walther B, Roel G, Maarten R. Renal cancer and the kidney in cancer. Nephrol Dial Transplant 2012. [DOI: 10.1093/ndt/gfs208] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
30
|
Stavridis E, Gatzioufas Z, Hasenfus A, Sauter M, Smola S, Seitz B. Ping-Pong-Transmission von Herpes-simplex-Virus 1 nach Hornhauttransplantation. Ophthalmologe 2012; 109:1017-21. [DOI: 10.1007/s00347-012-2569-0] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
31
|
Frost M, Budde K, Kingswood J, Zonnenberg B, Belousova E, Radzikowska E, Sauter M, Nonomura N, Brakemeier S, de Vries P, Sahmoud T, Shah G, Miao S, Gray D, Bissler J. Everolimus for the Treatment of Angiomyolipoma in Patients with Tuberous Sclerosis Complex or Sporadic Lymphangioleiomyomatosis: Results from EXIST-2 (P04.188). Neurology 2012. [DOI: 10.1212/wnl.78.1_meetingabstracts.p04.188] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
32
|
Ge S, Bekins B, Bredehoeft J, Brown K, Davis EE, Gorelick SM, Henry P, Kooi H, Moench AF, Ruppel C, Sauter M, Screaton E, Swart P, Tokunaga T, Voss C, Whitaker F. Fluid flow in sub-sea floor processes and future ocean drilling. ACTA ACUST UNITED AC 2011. [DOI: 10.1029/2003eo160002] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
33
|
Noubactep C, Licha T, Scott TB, Fall M, Sauter M. Exploring the influence of operational parameters on the reactivity of elemental iron materials. J Hazard Mater 2009; 172:943-951. [PMID: 19683386 DOI: 10.1016/j.jhazmat.2009.07.097] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/16/2009] [Revised: 07/20/2009] [Accepted: 07/21/2009] [Indexed: 05/28/2023]
Abstract
In an attempt to characterize material intrinsic reactivity, iron dissolution from elemental iron materials (Fe(0)) was investigated under various experimental conditions in batch tests. Dissolution experiments were performed in a dilute solution of ethylenediaminetetraacetate (Na(2)-EDTA - 2mM). The dissolution kinetics of 18 Fe(0) materials were investigated. The effects of individual operational parameters were assessed using selected materials. The effects of available reactive sites [Fe(0) particle size (<or=2.0mm) and metal loading (2-64 g L(-1))], mixing type (air bubbling, shaking), shaking intensity (0-250 min(-1)), and Fe(0) pre-treatment (ascorbate, HCl and EDTA washing) were investigated. The data were analysed using the initial dissolution rate (k(EDTA)). The results show increased iron dissolution with increasing reactive sites (decreasing particle size or increasing metal loading), and increasing mixing speed. Air bubbling and material pre-treatment also lead to increased iron dissolution. The main output of this work is that available results are hardly comparable as they were achieved under very different experimental conditions. A unified experimental procedure for the investigation of processes in Fe(0)/H(2)O systems is suitable. Alternatively, a parameter (tau(EDTA)) is introduced which could routinely used to characterize Fe(0) reactivity under given experimental conditions.
Collapse
Affiliation(s)
- C Noubactep
- Angewandte Geologie, Universität Göttingen, Goldschmidtstrasse 3, D-37077 Göttingen, Germany.
| | | | | | | | | |
Collapse
|
34
|
Noubactep C, Kurth AMF, Sauter M. Evaluation of the effects of shaking intensity on the process of methylene blue discoloration by metallic iron. J Hazard Mater 2009; 169:1005-1011. [PMID: 19442443 DOI: 10.1016/j.jhazmat.2009.04.046] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/03/2008] [Revised: 02/19/2009] [Accepted: 04/14/2009] [Indexed: 05/27/2023]
Abstract
The term mixing (shaking, stirring, agitating) is confusing because it is used to describe mass transfer in systems involving species dissolution, species dispersion and particle suspension. Each of these mechanisms requires different flow characteristics in order to take place with maximum efficiency. This work was performed to characterize the effects of shaking intensity on the process of aqueous discoloration of methylene blue (MB) by metallic iron (Fe(0)). The extent of MB discoloration by three different materials in five different systems and under shaking intensities varying from 0 to 300 min(-1) was directly compared. Investigated materials were scrap iron (Fe(0)), granular activated carbon (GAC), and deep sea manganese nodules (MnO(2)). The experiments were performed in essay tubes containing 22 mL of the MB solution (12 mg/L or 0.037 mM). The essay tubes contained either: (i) no reactive material (blank), (ii) 0-9.0 g/L of each reactive material (systems I, II and III), or (iii) 5g/L Fe(0) and 0 to 9.0g/L GAC or MnO(2) (systems IV and V). The essay tubes were immobilized on a support frame and shaken for 0.8-5 days. Non-shaken experiments lasted for duration up to 50 days. Results show increased MB discoloration with increasing shaking intensities below 50 min(-1), a plateau between 50 and 150 min(-1), and a sharp increase of MB discoloration at shaking intensities >or=200 min(-1). At 300 min(-1), increased MB discoloration was visibly accompanied by suspension of dissolution products of Fe(0)/MnO(2) and suspension of GAC fines. The results suggest that, shaking intensities aiming at facilitating contaminant mass transfer to the Fe(0) surface should not exceed 50 min(-1).
Collapse
Affiliation(s)
- C Noubactep
- Angewandte Geologie, Universität Göttingen, Goldschmidtstrasse 3, D-37077 Göttingen, Germany.
| | | | | |
Collapse
|
35
|
Abstract
The genomes of vertebrates contain sequences that are similar to present-day exogenous retroviruses. Such sequences, called endogenous retroviruses (ERVs), have resulted from ancestral germ line infections by exogenous retroviruses which have thereafter been transmitted in a Mendelian fashion. By analogy to exogenous tumorigenic retroviruses, ERVs have been implicated in the pathogenesis of cancer. Cumulative evidence from animal models indicates that ERVs may participate in the process of malignant transformation or promote tumor growth, e.g. through insertional mutagenesis or via counteracting tumor immunosurveillance. Here, we review the role of ERVs in tumorigenesis with focus on human ERVs (HERVs) in human cancer. Although available data suggest a potential role of HERVs in human cancers, in particular germ cell tumors, the contributions of HERVs to human tumorigenesis warrant further elucidation. (Part of a multi-author review).
Collapse
Affiliation(s)
- K Ruprecht
- Institut für Virologie, Universitätsklinikum des Saarlandes, Homburg, Saar, Germany
| | | | | | | | | |
Collapse
|
36
|
Ballard C, Sauter M, Scheltens P, He Y, Barkhof F, van Straaten ECW, van der Flier WM, Hsu C, Wu S, Lane R. Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study. Curr Med Res Opin 2008; 24:2561-74. [PMID: 18674411 DOI: 10.1185/03007990802328142] [Citation(s) in RCA: 104] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
OBJECTIVE The aim was to evaluate the efficacy, safety and tolerability of rivastigmine capsules in patients diagnosed with probable vascular dementia (VaD). METHODS VantagE (Vascular Dementia trial studying Exelon) was a 24-week, multicentre, double-blind study. VaD patients aged 50-85 years were randomized to rivastigmine capsules (3-12 mg/day) or placebo. Efficacy assessments included global and cognitive performances, activities of daily living and neuropsychiatric symptoms. Adverse events were recorded. Additional exploratory analyses determined whether heterogeneity in pathologies and symptoms extended to differential treatment effects. TRIAL REGISTRATION NCT00099216. RESULTS 710 patients were randomized. Rivastigmine demonstrated superiority over placebo on three measures of cognitive performance (Vascular Dementia Assessment Scale, Alzheimer's Disease Assessment Scale cognitive subscale, Mini-Mental State Examination; all p< or = 0.05, intent-to-treat population [ITT]), but not other outcomes. Predominant adverse events were nausea and vomiting. Exploratory analyses indicated that older patients (> or =75 years old), assumed more likely to also have Alzheimer's disease (AD) pathology, demonstrated significant cognitive responses to rivastigmine and a safety profile similar to that seen in AD patients. Younger patients, assumed less likely to have concomitant AD pathology, showed no efficacy response and were associated with slight elevations of blood pressure, cerebrovascular accidents and mortality. Rivastigmine-placebo differences in patients with, versus those without, medial temporal atrophy (also suggestive of concomitant AD) showed a numerical difference similar to that seen between the older versus younger patients, but did not attain statistical significance. CONCLUSION Consistent with trials evaluating other cholinesterase inhibitors, rivastigmine did not provide consistent efficacy in probable VaD. The efficacy apparent on cognitive outcomes was derived from effects in older patients likely to have concomitant Alzheimer pathology. This is supportive of an existing argument that the putative cholinergic deficit in VaD reflects the presence of concomitant Alzheimer pathology.
Collapse
Affiliation(s)
- C Ballard
- Wolfson Centre for Age-Related Diseases, King's College, London, UK.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Mozaffarieh M, Schoetzau A, Sauter M, Grieshaber M, Orgül S, Golubnitschaja O, Flammer J. Comet assay analysis of single-stranded DNA breaks in circulating leukocytes of glaucoma patients. Mol Vis 2008; 14:1584-8. [PMID: 18769648 PMCID: PMC2526097] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2008] [Accepted: 08/25/2008] [Indexed: 11/01/2022] Open
Abstract
PURPOSE To investigate the amount of single-stranded DNA breaks in circulating leukocytes of primary open-angle glaucoma (POAG) patients. METHODS A comparative quantification of DNA breaks was performed in circulating leukocytes of POAG patients and healthy controls. The following groups of subjects were compared: (1) POAG patients having primary vascular dysregulation (PVD), (2) POAG patients without PVD, (3) healthy controls with PVD, and (4) healthy controls without PVD. The damage to DNA resulting in single-stranded breaks was assessed by means of the alkaline comet assay in which the damaged DNA migrates out of the nucleus forming a tail, which can be quantified using image analysis. Damage was quantified as the comet tail moment, which represents the extent of DNA damage in individual cells. RESULTS Leukocytes of POAG patients exerted a significantly higher amount of comet tails, which are indicative of DNA damage, in comparison to control leukocytes (p<0.001). DNA breaks occurred particularly in the subgroup of POAG patients with PVD in comparison to glaucoma patients without PVD (p=0.002). In the control group, there was no significant difference between controls with PVD and controls without PVD (p=0.86). CONCLUSIONS POAG patients with PVD have a significantly higher rate of DNA breaks than both POAG patients without PVD and healthy controls with and without PVD.
Collapse
Affiliation(s)
| | | | - M Sauter
- University Eye Clinic, Basel, Switzerland
| | | | - S Orgül
- University Eye Clinic, Basel, Switzerland
| | | | - J Flammer
- University Eye Clinic, Basel, Switzerland
| |
Collapse
|
38
|
Sauter M, Anders HJ. Lupus nephritis. Minerva Med 2007; 98:749-758. [PMID: 18299686] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
Lupus nephritis is a common complication of systemic lupus erythematosus (SLE). Early recognition of lupus nephritis requires routine serum creatinine determination, urinalysis and urinary microscopy. Since mild urinary abnormalities such as leucocyturia or proteinuria can be associated with severe lupus nephritis, a renal biopsy is usually indicated in patients with SLE and urinary abnormalities. A renal biopsy is required to determine the class of lupus nephritis which is based on histopathological criteria which have recently been revised. Aggressive immunosuppressive therapy is indicated in diffuse proliferative lupus nephritis. In class III or class V the treatment indication depends on additional prognostic criteria. Intravenous cyclophosphamide is still used but doses and intervals have been modified based on large clinical trials. Mycopheno-late may establish as an alternative for cyclophosphamide in the induction phase, but the data of the transcontinental multicenter Aspreva Lupus Management Study (ALMS) trial have not yet been published in detail. Controlled clinical trials support the use of azathioprine and mycophenolate for maintaining remission of lupus nephritis, and cyclophosphamide is no longer used in that phase. Additional control of cardiovascular risk factors and combined angiotensin and angiotensin receptor blockade are mandatory for all proteinuric SLE patients. Novel treatment options are ahead of us based on the molecular mechanisms of SLE and lupus nephritis, but as evidence from controlled clincial trials is still lacking they are not yet approved for broad clinical use. However, the treatment options for severe lupus nephritis have been improved and are likely to further improve in the near future.
Collapse
Affiliation(s)
- M Sauter
- Department of Nephrology, Medical Policlinic, University of Munich, Germany
| | | |
Collapse
|
39
|
Nitschke I, Sauter M, Sobotta B, Reiber T. Die zahnmedizinische Versorgung von Senioren – auch eine Herausforderung für den Öffentlichen Gesundheitsdienst. Gesundheitswesen 2007. [DOI: 10.1055/s-2007-982839] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
40
|
|
41
|
Friedrich B, Wärntges S, Klingel K, Sauter M, Kandolf R, Risler T, Müller GA, Witzgall R, Kriz W, Gröne HJ, Lang F. Up-regulation of the human serum and glucocorticoid-dependent kinase 1 in glomerulonephritis. Kidney Blood Press Res 2003; 25:303-7. [PMID: 12435876 DOI: 10.1159/000066794] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
Glomerulonephritis is paralleled by excessive formation of transforming growth factor-beta (TGF-beta), which participates in the pathophysiology of the disease. Recently, a novel downstream target of TGF-beta has been identified, i.e. the human serum and glucocorticoid-dependent kinase 1 (hSGK1), a serine/threonine kinase participating in the regulation of Na(+) transport. The present study was performed to elucidate transcriptional regulation of hSGK1 in glomerulonephritis. To this end, in situ hybridization was performed in biopsies from patients with clinical diagnosis of glomerulonephritis. hSGK1 transcript levels were moderately enhanced in 5 out of 9 patients and strongly enhanced in 4 out of 9 patients. Distal nephron epithelial cell hSGK1 transcript levels were low or absent in 7 of the 9 patients but markedly enhanced in 2 of the 9 patients. In conclusion, glomerulonephritis leads to glomerular and in some cases to epithelial up-regulation of hSGK1 transcription.
Collapse
Affiliation(s)
- B Friedrich
- Department of Physiology, University of Tübingen, Germany
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
42
|
Sauter M, Licha T. Use of Short Chained Alkylphenols (SCAP) in Analysis of Transport Behaviour of Oil Contaminated Groundwater. Jour Agri & Mar Scie 2002. [DOI: 10.24200/jams.vol7iss2pp29-37] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
Shortchained alkylphenols (SCAP) represent a main constituent of crude oil and coal liquefaction products. Due to their specific oil/water partitioning behaviour and high aqueous solubility they can be detected in oil exploitation waters and groundwaters affected by various spills near oil pipelines, oil exploitation sites and coal liquefaction plants. New efficient and powerful analytical techniques have been developed that allow the identification of all 34 individual compounds (C0-C3) without derivatisation and in complex matrices. Due to the different physico-chemical properties of the SCAP, differential transport behaviour in groundwater can be observed, changing the relative concentrations of SCAP downgradient in space and time. These characteristic ratios can be employed to derive information on migration direction and the ageing of the source of contamination. A case study is presented to illustrate the use of this new tool.
Collapse
|
43
|
Younger PL, Teutsch G, Custodio E, Elliot T, Manzano M, Sauter M. Assessments of the sensitivity to climate change of flow and natural water quality in four major carbonate aquifers of Europe. ACTA ACUST UNITED AC 2002. [DOI: 10.1144/gsl.sp.2002.193.01.23] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
AbstractA numerical modelling approach has been developed to predict the vulnerability of aquifers to future climate change. This approach encompasses changes in recharge regime, dynamics of flow and storage patterns within aquifers, and natural hydrochemical changes. An application of the approach has been made to four hypothetical spring catchments representative of major carbonate aquifers in three European climatic zones. Since prolific carbonate aquifers typically combine a high transmissivity with a low specific yield, they can be expected to be more sensitive than clastic aquifers to changes in recharge patterns. Simulations of the study systems to the middle of the 21st century predict different outcomes in the three different climate zones: (1) in the northern maritime zone (UK) recharge (and therefore discharge) is predicted to increase by as much as 21 0n response to anticipated increases in precipitation; (2) in the continental zone (Germany) recharge in winter is predicted to remain approximately the same as at present, but summer recharge will decline dramatically (by as much as 32%), so that a net decrease in aquifer discharge is predicted; and (3) in the Mediterranean zone (Spain) recharge is predicted to decrease by as much as 160f the present-day values. For all three systems, increases in water hardness in response to rising CO2 are predicted, but are expected to be negligible in water resources terms.
Collapse
Affiliation(s)
- P. L. Younger
- Water Resource Systems Research Laboratory, Department of Civil Engineering, University of Newcastle Upon Tyne
UK
| | - G. Teutsch
- Lehrstuhl für Angewändte Geologie, Eberhard-Karls Universität Tübingen
Germany
| | - E. Custodio
- Departamento de Ingeniería de Terreno, Universitat Politécnica de Catalunya
Spain
| | - T. Elliot
- Water Resource Systems Research Laboratory, Department of Civil Engineering, University of Newcastle Upon Tyne
UK
- School of Civil Engineering, Queen’s University
Belfast
| | - M. Manzano
- Departamento de Ingeniería de Terreno, Universitat Politécnica de Catalunya
Spain
| | - M. Sauter
- Lehrstuhl für Angewändte Geologie, Eberhard-Karls Universität Tübingen
Germany
- Geologisches Institut, Universität Jena
Germany
| |
Collapse
|
44
|
Abstract
Sequences homologous to the human endogenous retrovirus (HERV) family HERV-K(HML-2) are present in all Old World primate species. A previous study showed that a central region of the HERV-K(HML-2) gag genes in Hominoidea species displays a 96-bp deletion compared to the gag genes in lower Old World primates. The more ancient HERV-K(HML-2) sequences present in lower Old World primates were apparently not conserved during hominoid evolution, as opposed to the deletion variants. To further clarify the evolutionary origin of the HERV-K(HML-2) family, we screened GenBank with the 96-bp gag-sequence characteristic of lower Old World primates and identified, to date, 10 human sequence entries harboring either full-length or partially deleted proviral structures, probably representing remnants of a more ancient HERV-K(HML-2) variant. The high degree of mutations demonstrates the long-time presence of these HERV-K(OLD) proviruses in the genome. Nevertheless, they still belong to the HML-2 family as deduced from dot matrix and phylogenetic analyses. We estimate, based on the family ages of integrated Alu elements and on long terminal repeat (LTR) divergence data, that the average age of HERV-K(OLD) proviruses is ca. 28 million years, supporting an integration time before the evolutionary split of Hominoidea from lower Old World primates. Analysis of HERV-K(OLD) LTR sequences led to the distinction of two subgroups, both of which cluster with LTRs belonging to an evolutionarily older cluster. Taken together, our data give further insight into the evolutionary history of the HERV-K(HML-2) family during primate evolution.
Collapse
Affiliation(s)
- K Reus
- Institut für Humangenetik, Universitätskliniken des Saarlandes, Homburg/Saar, Germany
| | | | | | | | | | | |
Collapse
|
45
|
Abstract
Expression of human endogenous retrovirus K (HERV-K) is associated with germ-cell neoplasia. HERV-K encodes a protein of the Rev/Rex family, cORF, that supports cellular transformation and binds the promyelocytic leukemia zinc finger (PLZF) protein implicated in spermatogenesis. Rev/Rex function invariably depends on multimerization. Here we show that cORF likewise self-associates to form higher-order oligomers. Amino acids (aa) 47-87 in cORF are sufficient, aa 75-87 essential for self-association. Consistently, this domain is predicted to form a hydrophobic alpha-helix that may represent an oligomerization interface. The existence of a dimerization-competent cORF mutant lacking PLZF-binding activity (cORF47-87) suggests a way of dominant negative inhibition of the proposed tumor susceptibility factor cORF.
Collapse
Affiliation(s)
- A Boese
- Institut für Medizinische Mikrobiologie und Hygiene, Abteilung, Virologie, Haus 47, 66421 Hamburg, Germany
| | | | | | | | | |
Collapse
|
46
|
Reus K, Mayer J, Sauter M, Scherer D, Müller-Lantzsch N, Meese E. Genomic organization of the human endogenous retrovirus HERV-K(HML-2.HOM) (ERVK6) on chromosome 7. Genomics 2001; 72:314-20. [PMID: 11401447 DOI: 10.1006/geno.2000.6488] [Citation(s) in RCA: 41] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Recently, we reported an almost intact human endogenous retrovirus (HERV-K(HML-2.HOM); HGMW-approved symbol ERVK6) located on human chromosome 7, with open reading frames for all retroviral genes and a mutation only within the reverse transcriptase. We further characterized the genomic organization of this endogenous retrovirus by subcloning and sequencing of the proviral insert contained within a chromosome 7-specific cosmid clone and found HERV-K(HML-2.HOM) to be organized as a tandem repeat. Examination of various human DNA samples for this specific proviral repeat suggests a relatively ubiquitous distribution of the HERV-K(HML-2.HOM) tandem structure. However, we identified two human samples having only a single provirus at this locus. In addition, we investigated the presence of HERV-K(HML-2.HOM) alleles having an intact YXDD motif within the reverse transcriptase domain by sequencing the corresponding polymerase gene from various human DNA samples. We identified a HERV-K(HML-2.HOM) polymerase with an intact YXDD motif in two samples, thus potentially coding for an active reverse transcriptase. Our results show for the first time an endogenous retrovirus tandem repeat in human populations and suggest the existence of alleles harboring an intact human endogenous retrovirus including an intact polymerase gene.
Collapse
Affiliation(s)
- K Reus
- Institut für Humangenetik, Institut für Medizinische Mikrobiologie und Hygiene, Homburg/Saar, Germany
| | | | | | | | | | | |
Collapse
|
47
|
Klingel K, Wärntges S, Bock J, Wagner CA, Sauter M, Waldegger S, Kandolf R, Lang F. Expression of cell volume-regulated kinase h-sgk in pancreatic tissue. Am J Physiol Gastrointest Liver Physiol 2000; 279:G998-G1002. [PMID: 11052997 DOI: 10.1152/ajpgi.2000.279.5.g998] [Citation(s) in RCA: 37] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
Transcript levels of the human serine/threonine kinase h-sgk have been found to be highest in pancreas. In the present study, localization and regulation of h-sgk transcription in pancreatic tissue were elucidated. As was apparent from radioactive in situ hybridization, most pancreatic acinar cells expressed high levels of h-sgk mRNA. h-sgk mRNA-positive cells were also found in ductal epithelia but not in pancreatic islets. In biopsy specimens from patients with pancreatitis, h-sgk mRNA levels were decreased in acinar cells but abundant in numerous mononuclear interstitial cells within areas of pancreatic necrosis and fibrosis. As shown by Northern blotting, h-sgk transcription in DAN-G pancreatic tumor cells is upregulated by osmotic cell shrinkage, serum, phorbol esters (phorbol 12,13-didecanoate), and Ca(2+) ionophore A-23187 and decreased by staurosporine and cAMP. In conclusion, h-sgk transcription is regulated not only by cell volume but also by serum, protein kinase C stimulation, cAMP, and increase of intracellular Ca(2+) activity. The kinase may participate not only in normal function of exocrine pancreas but also in fibrosing pancreatitis.
Collapse
Affiliation(s)
- K Klingel
- Department of Molecular Pathology, Institute of Pathology, University of Tübingen, D-72076, Tübingen, Germany
| | | | | | | | | | | | | | | |
Collapse
|
48
|
Mergemann H, Sauter M. Ethylene induces epidermal cell death at the site of adventitious root emergence in rice. Plant Physiol 2000; 124:609-14. [PMID: 11027711 PMCID: PMC59167 DOI: 10.1104/pp.124.2.609] [Citation(s) in RCA: 84] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/13/2000] [Accepted: 06/23/2000] [Indexed: 05/18/2023]
Abstract
In deepwater rice (Oryza sativa), adventitious root primordia initiate at the nodes as part of normal development. Emergence of the roots is dependent on flooding of the plant and is mediated by ethylene action. Root growth was preceded by the induced death of epidermal cells of the node external to the tip of the root primordium. Cell death proceeded until the epidermis split open. Through this crack the root eventually emerged. Induced death was confined to nodal epidermal cells covering the tip of the primordia. Our results suggest that this process facilitates adventitious root emergence and prevents injury to the growing root. Cell death was inducible not only by submergence but also by application of 1-aminocyclopropane-1-carboxylic acid, the natural precursor of ethylene and it was suppressed in the presence of 2,5-norbornadiene (bicyclo[2.2.1]hepta-2,5-diene), an inhibitor of ethylene action. Adventitious root growth and epidermal cell death are therefore linked to the ethylene signaling pathway, which is activated in response to low oxygen stress.
Collapse
Affiliation(s)
- H Mergemann
- Institut für Allgemeine Botanik, Ohnhorststrasse 18, 22609 Hamburg, Germany
| | | |
Collapse
|
49
|
Yamaguchi M, Fabian T, Sauter M, Bhalerao RP, Schrader J, Sandberg G, Umeda M, Uchimiya H. Activation of CDK-activating kinase is dependent on interaction with H-type cyclins in plants. Plant J 2000; 24:11-20. [PMID: 11029700 DOI: 10.1046/j.1365-313x.2000.00846.x] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/18/2023]
Abstract
cDNAs encoding cyclin H homologs were isolated from poplar (Populus tremula X tremuloides) and rice (Oryza sativa) plants, and were designated Pt;cycH;1 and Os;cycH;1, respectively. The deduced amino-acid sequences showed 40-60% similarity to human cyclin H and Schizosaccharomyces pombe Mcs2, with higher similarity in the cyclin box region. While Pt;cycH;1 and Os;cycH;1 were expressed in all tissues examined, the transcripts accumulated abundantly in dividing cells. Expression of Os;cycH;1 was abundant in the S-phase in partially synchronized suspension cells, and was induced by submergence in internodes of deepwater rice. A yeast two-hybrid assay demonstrated that both Pt;CycH;1 and Os;CycH;1 were able to interact with rice R2 kinase, which is structurally and functionally similar to cyclin-dependent kinase (CDK)-activating kinase (CAK) of vertebrates. Moreover, an in vitro pull-down assay showed that Os;CycH;1 specifically bound to R2 but not to other rice CDKs. When R2 was expressed in budding yeast CAK mutant, the suppression activity in terms of temperature-sensitivity was enhanced by co-expression with Os;cycH;1. Furthermore, in vitro kinase assay indicated that the kinase activities of R2 on CDKs and the carboxy-terminal domain (CTD) of the largest subunit of RNA polymerase II were markedly elevated by binding to Os;CycH;1. Our results suggest that cyclin H is a regulatory subunit of CAK, which positively controls CDK- and CTD-kinase activities in plant cells.
Collapse
Affiliation(s)
- M Yamaguchi
- Institute of Molecular and Cellular Biosciences, The University of Tokyo, Yayoi 1-1-1, Bunkyo-ku, Tokyo 113-0032, Japan
| | | | | | | | | | | | | | | |
Collapse
|
50
|
Boese A, Sauter M, Galli U, Best B, Herbst H, Mayer J, Kremmer E, Roemer K, Mueller-Lantzsch N. Human endogenous retrovirus protein cORF supports cell transformation and associates with the promyelocytic leukemia zinc finger protein. Oncogene 2000; 19:4328-36. [PMID: 10980608 DOI: 10.1038/sj.onc.1203794] [Citation(s) in RCA: 99] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Human endogenous retrovirus sequences (HERVs) reside in the genomes of primates and humans for several million years. The majority of HERVs is non-coding but a limited set is intact and can express proteins. We have recently identified an almost intact HERV-K(HML-2) provirus on chromosome 7 and have documented that most patients with germ cell tumors (GCTs) display antibodies directed against proteins of HERV-K(HML-2). To address whether these proteins merely represent tumor markers or contribute to neoplastic transformation, we examined the transforming potential of various HERV sequences and studied physical interactions between HERV and cellular proteins by yeast two-hybrid and biochemical assays. cORF, a protein encoded by the C-terminal open reading frame within the env gene, supports tumor growth in nude mice and associates with the promyelocytic leukemia zinc finger protein (PLZF). The interaction domains map between amino acid residues 21 and 87 of cORF, and between residues 245 and 543 of PLZF. PLZF is critical for spermatogenesis in mice. Abnormal spermatogenesis or maturation of gonocytes is thought to predispose humans to the development of germ cell tumors. Thus, cORF of human endogenous retroviruses may contribute to tumor development by interfering with processes during spermatogenesis that involve PLZF.
Collapse
Affiliation(s)
- A Boese
- Department of Virology, Building 47, University of the Saarland Medical School, D-66421 Homburg/Saar, Germany
| | | | | | | | | | | | | | | | | |
Collapse
|